Linoleic Acid.

Linoleic acid is converted to gamma-linolenic acid by delta-6 desaturase, the rate limiting step of the omega-6 chain. Supplying GLA directly bypasses that step, which is why the two show up together in skin formulas.

Evening primrose oil is roughly three quarters linoleic acid with a smaller GLA fraction, so it delivers substrate and the downstream metabolite together. Adding separate linoleic acid mainly raises the substrate side of that ratio.

Borage oil carries the highest common GLA fraction and also contains linoleic acid, so the two overlap on the same desaturation pathway. Total omega-6 intake should be read across both.

Linoleic acid and alpha-linolenic acid compete for the same delta-6 desaturase enzyme, and a high linoleic load lowers the fraction of alpha-linolenic acid that is elongated onward. The balance between the two matters more than the absolute amount of either.

Arachidonic acid made from linoleic acid and EPA compete for the same cyclooxygenase and lipoxygenase enzymes, producing different eicosanoid series. Raising linoleic acid shifts that competition toward the omega-6 series.

Membrane phospholipids incorporate omega-6 and omega-3 fatty acids from the same dietary pool, so the two ingredients set each other's share. Formulas that raise linoleic acid usually pair fish oil to hold the ratio.

Linoleic acid has two double bonds that are readily oxidised, and alpha-tocopherol is the chain-breaking antioxidant that halts that propagation in membranes. Vitamin E need rises roughly in step with polyunsaturated fat intake, which is textbook nutrition.

Delta-6 desaturase activity falls when zinc status is low, slowing the conversion of linoleic acid to gamma-linolenic acid. Adequate zinc keeps the first step of the pathway moving.

Pyridoxine is among the micronutrients reported to be required for normal desaturase and elongase function in the omega-6 chain. Where B6 status is marginal, linoleic acid converts onward less readily.

The skin's acylceramide species carry linoleic acid at a specific position and the barrier depends on that residue for its lamellar structure. Supplying both the ceramide and its signature fatty acid addresses two parts of one structure.

CLA isomers are conjugated forms of linoleic acid and enter the same desaturation and beta-oxidation machinery, so they compete with the parent fatty acid. Total linoleic-family intake should be counted across both entries.

Linoleic acid is desaturated to gamma-linolenic acid, elongated to dihomo-gamma-linolenic acid and desaturated again to arachidonic acid. Dietary linoleic acid is therefore the upstream supply for the arachidonic acid pool in tissue phospholipids. Conversion in adults is limited and varies between people. Supplying arachidonic acid directly bypasses the two desaturase steps entirely.

Alpha-linolenic acid from flaxseed and linoleic acid are handled by the same delta-6 desaturase, and the enzyme prefers the omega-3 substrate. A high linoleic acid intake reduces the fraction of alpha-linolenic acid that proceeds down the omega-3 chain, and the same is true in the other direction. This is one of the oldest described interactions in fatty acid nutrition. It concerns the ratio of the two intakes rather than either one alone.

Long-chain omega-3 and omega-6 fatty acids compete for the same desaturase and elongase enzymes and for incorporation into the same membrane phospholipid positions. A high linoleic acid intake shifts the membrane composition toward omega-6 derived species. Providing preformed DHA sidesteps the enzymatic competition. The interaction is compositional and measured in tissue fatty acid profiles.

Free long-chain fatty acids form insoluble calcium soaps in the alkaline environment of the small intestine, which reduces the absorption of both the fatty acid and the calcium. The effect is largest when free fatty acids rather than intact triglycerides are present at high load. Formulators usually separate a large calcium dose from a large free fatty acid dose. This is absorption chemistry, not an effect on any outcome.

The desaturases that act on linoleic acid receive their electrons through cytochrome b5 and cytochrome b5 reductase, a flavoprotein that requires FAD derived from riboflavin. Without adequate riboflavin the electron supply to that step is constrained. This is a textbook cofactor dependency rather than an effect measured in a supplementation trial.

Delta-6 and delta-5 desaturases are diiron enzymes that need a non-haem iron centre at the active site to insert a double bond. Iron status therefore sits upstream of linoleic acid conversion. The dependency is structural biochemistry; it does not imply that added iron increases conversion in someone already replete.

Glutathione peroxidase 4 is a selenoenzyme that reduces lipid hydroperoxides inside membranes, including those formed from linoleic acid. Polyunsaturated fatty acids are the most oxidation-prone lipids in a membrane, so selenium status is directly relevant to how they are handled. The relationship is enzymatic and established.

Glutathione is the reducing substrate that glutathione peroxidase uses to convert lipid hydroperoxides into the corresponding alcohols. Linoleic acid hydroperoxides are among the substrates of that reaction. The pairing describes normal cellular lipid redox handling.

Ascorbate regenerates the tocopheroxyl radical at the membrane surface, restoring the chain-breaking antioxidant that protects polyunsaturated fatty acids such as linoleic acid from peroxidation. The relationship is between vitamin C and vitamin E, with linoleic acid as the lipid being protected. It is settled redox chemistry.

Linoleic acid has two bis-allylic hydrogens and oxidises readily in the bottle and in the body. Mixed tocopherols are the standard chain-breaking antioxidant added to polyunsaturated oils, with gamma-tocopherol contributing activity against nitrogen-derived oxidants that alpha-tocopherol handles less well. The pairing is about stability of the oil and of the membrane lipid.

Rosemary extract standardised on carnosic acid and carnosol is widely used with tocopherols to slow peroxide formation in polyunsaturated seed oils. The two work at different points in the oxidation chain, which is why they are usually combined. The purpose is shelf stability of the material, not a physiological effect.

Astaxanthin spans the membrane bilayer and intercepts radicals at both polar surfaces, a position complementary to tocopherol. Linoleic acid rich membranes are the substrate being protected in both cases. The rationale is chemical rather than clinical.

Linoleic acid is the dominant fatty acid esterified at the sn-2 position of sunflower lecithin phospholipids, so lecithin is both a delivery vehicle and a linoleic acid source in its own right. Phospholipid-bound fatty acids follow a partly different absorption route from triglycerides. Anyone counting total linoleic acid intake should count the lecithin.

Carotenoid absorption depends on dietary fat to trigger bile release and to form the mixed micelles that carry them across the enterocyte membrane. Linoleic acid rich oils are the fat most often used for that purpose in a supplement. The relationship is a delivery one and applies to any long-chain fat.

Lutein taken without fat is poorly absorbed because it cannot enter mixed micelles efficiently. A linoleic acid rich oil in the same capsule supplies that fat. The effect is on the amount absorbed, a pharmacokinetic measure.

Cholecalciferol is fat-soluble and is routinely dissolved in a seed oil high in linoleic acid for softgel filling. The oil provides both the solvent and the fat stimulus for bile release. It does not alter what the vitamin does once absorbed.

Coenzyme Q10 is a crystalline lipid with poor dissolution, and suspension in a polyunsaturated oil is one of the standard ways to present it. Linoleic acid rich oils keep it dispersed and supply the accompanying fat. This is a delivery pairing.

Oleic acid and linoleic acid compete for the same acyltransferases when fatty acids are esterified into phospholipids and triglycerides. A diet or formula dominated by oleic acid shifts membrane composition away from the polyunsaturated species. The interaction is compositional and shows up in tissue fatty acid profiles.